Calciphylaxis is a rare dermatological condition strongly associated with chronic kidney disease. The pathophysiology and optimum treatment remain uncertain. Calciphylaxis is known mostly to affect dialysis patients but is less frequently reported in renal transplant recipients. We report the case of a renal transplant recipient who had undergone previous total parathyroidectomy.
TanSWWongJKeeT, et al. Successful treatment of calciphylaxis in a renal transplant recipient with combination of intralesional sodium thiosulphate, intravenous sodium thiosulphate and fish skin graft. Australas J Dermatol2021; 62: e358–9.
2.
DosanjhAKebebewE. Calciphylaxis: rare but Fatal. Curr Surg2005; 62: 455–8.
3.
ChinnaduraiRHuckleAHegartyJ, et al. Calciphylaxis in end-stage kidney disease: outcome data from the United Kingdom Calciphylaxis Study. J Nephrol2021; 34: 1537–45.
4.
McCarthyJTEl-AzharyRAPatzeltMT, et al. Survival, risk factors, and effect of treatment in 101 patients with calciphylaxis. Mayo Clin Proc2016; 91: 1384–94.
5.
MazharARJohnsonRJGillenD, et al. Risk factors and mortality associated with calciphylaxis in end-stage renal disease. Kidney Int2001; 60: 324–32.
6.
BrandenburgVMKramannRRotheH, et al. Calcific uraemic arteriolopathy (calciphylaxis): data from a large nationwide registry. Nephrol Dial Transplant2016; 32: 126–32.
7.
GabelCKChakralaTDobryAS, et al. The Koebner phenomenon may contribute to the development of calciphylaxis: a case series. JAAD Case Rep2021; 13: 57–61.
8.
VedvyasCWinterfieldLSVleugelsRA. Calciphylaxis: a systematic review of existing and emerging therapies. J Am Acad Dermatol2012; 67: e253–6.
9.
UdomkarnjananunSKongnatthasateKPraditpornsilpaK, et al. Treatment of calciphylaxis in CKD: a systematic review and meta-analysis. Kidney Int Rep2019; 4: 231–44.
10.
NigwekarSUBrunelliSMMeadeD, et al. Sodium thiosulfate therapy for calcific uremic arteriolopathy. Clin J Am Soc Nephrol2013; 8: 1162–70.
11.
PodestàMACiceriPGalassiA, et al. Calciphylaxis after kidney transplantation: a rare but life-threatening disorder. Clin Kidney J2022; 15: 611–4.
CaluweRVandecasteeleSVan VlemB, et al. Vitamin K2 supplementation in haemodialysis patients: a randomized dose-finding study. Nephrol Dial Transplant2014; 29: 1385–90.
14.
ChristiadiDSingerRF. Calciphylaxis in a dialysis patient successfully treated with high-dose vitamin K supplementation. Clin Kidney J2018; 11: 528–9.
15.
DeenJSchaiderH. The use of cinacalcet for the treatment of calciphylaxis in patients with chronic kidney disease: a comprehensive review. Australas J Dermatol2019; 60: e186–94.
16.
WeenigRHSewellLDDavisMDP, et al. Calciphylaxis: natural history, risk factor analysis, and outcome. J Am Acad Dermatol2007; 56: 569–79.
17.
KatikaneniMLwinLVillanuevaH, et al. Calciphylaxis and subtotal parathyroidectomy: a double-edged sword. Hemodial Int2013; 17: S33–6.
